Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1998

View Archived Issues

Roberts seeks to broaden market for Agrylin

Sumitomo and Genentech collaborate on two GH products

Ribozyme HIV gene therapy demonstrates potential in phase I/II

Chemogene therapy: a new therapeutic approach on the horizon?

Cellegy acquires Anogesic

Advanced Polymer Systems and Pharmacia & Upjohn collaborate on new drug formulation

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Efficacy established for ET antagonist in pulmonary hypertension

New muscarinic receptor modulators from Lilly

Novo Nordisk discloses peripheral muscarinic cholinergic agonists

Lusofarmaco develops new angiotensin antagonists

Selective COX-2 inhibitors under study at Merck Frosst

GH release-stimulating compounds reported by Novo Nordisk

Akzo patents benzylamines for depression

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Pharmacia & Upjohn prepares MMP inhibitors

Temodal submitted for approval in E.U.

Two new launches for Emdogain

IND submitted for new atherosclerosis imaging agent from Diatide

GeneMedicine will not conduct scheduled clinical trial of IGF-I Gene Medicine

Synaptic and Gruenenthal initiate pain collaboration

Analog II: a novel antiestrogen with selective activity against breast cancer

New anticancer combination associated with high efficacy in phase II metastatic breast cancer trial

Takeda announces changes in Japanese and European business strategies

Neupogen approved for use in AIDS patients

ProAmatine filed for approval in U.K.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...